HCM City (VNA) – Vietnam’s pharmaceutical market⭕ which is worth 3.5 billion USD is attractive to Indian enterprises, according to Operational Director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) Ravi Uduy Bhaskar.
Addressing a Vietnam-India trading exchange programme for the pharmaceutical sector in Ho Chi Minh City on March 17, the director said significant changes in laws and mechanisms regulating the sector in Vietnam have encouraged Indian enterprises to consider greater presence in the Southeast Asian country’s market.
The Deputy Director of Ho Chi Minh City branch of the Vietnam Chamber of Commerce and Industry (VCCI), Vu Thu Hang, revealed Vietnam’s pharmaceutical sector is expected to growth at an annual growth of 16 percent from now to 2020.
Meanwhile, India has an advantage in science, technology, the pharmaceutical industry and chemistry, hence cooperation in the field would help bilateral trade and investment in the area, she added.
Hoang Thanh Mai from the Vietnam Pharmaceutical Management Department stressed Vietnam’s authorities have always created the best possible conditions for enterprises, including those from India.
The department has cooperated with many local and international entities to boost the application of information technology in managing activities such as medicine registration, price declaration and information registration, she noted.
The department is working to refine the regulation system in the area towards meeting both the domestic requirements and international best practice, she concluded.
According to the department, among 7,630 valid registered foreign medicines in Vietnam, 2,814 are of Indian companies. Indian companies number 200 among 718 foreign companies operating in medicine and medicine material in the country. They not only supply regular generic medicines but also highly specialized drugs which Vietnam is not able to produce at present.-VNA
Vietnam 's pharmaceutical market will continue to grow rapidly by roughly 25 percent per year to be worth around 2 billion USD by 2012, according to the Drug Administration of Vietnam.
More and more domestic pharmaceutical firms have recently announced plans to expand their production as the market has shown signs of picking up in recent months, an English language news website reported.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
According to the World Health Organisation, more than 25,000 COVID-19 cases have been recorded globally over the past month. Notably, from January 1 to May 10, Thailand reported nearly 54,000 infections and 16 deaths. The rise in cases in Thailand has been linked to the spread of XBB.1.16 subvariant.
Illustrative image (Source: ajp.com.au)
